Cerebrovascular Disorders

• 

  Subject Areas on Research

  • A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke. 
  • A follow-up survey of clinical practices for the use of heparin, warfarin, and aspirin. 
  • A linear models application of competing risks to multiple causes of death. 
  • A mathematical model of the physiological dynamics of aging and correlated mortality selection: II. Application to the Duke Longitudinal Study. 
  • A multiple cause of death analysis of hypertension-related mortality in North Carolina, 1968-1977. 
  • A practical approach to CT angiography of the neck and brain. 
  • APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds. 
  • Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. 
  • Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. 
  • Acute febrile cerebrovasculitis. A non-spotted fever group rickettsial disease. 
  • Acute stroke: evaluation with serial proton MR spectroscopic imaging. 
  • Advances in primary stroke prevention. 
  • Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. 
  • Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. 
  • Aggressive therapy of acute MI in the elderly. 
  • Alpers' syndrome presenting with seizures and multiple stroke-like episodes in a 17-year-old male. 
  • American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. 
  • Amphetamine-facilitated poststroke recovery. 
  • An analysis of the heterogeneity of U.S. nursing home patients. 
  • An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. 
  • Anesthesia for interventional neuroradiology. 
  • Angiotensin converting enzyme and genetic hypertension: cloning of rat cDNAs and characterization of the enzyme. 
  • Ankle-brachial index, cognitive impairment and cerebrovascular disease in a Chinese population. 
  • Antiphospholipid antibodies: findings at arteriography. 
  • Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis. 
  • Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. 
  • ApoE genotype and survival from intracerebral haemorrhage. 
  • Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects. 
  • Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. 
  • Aspiration following stroke: clinical correlates and outcome. 
  • Aspiration in bilateral stroke patients. 
  • Aspiration in bilateral stroke patients: a validation study. 
  • Assessing uncertainty in cost-effectiveness analyses: application to a complex decision model. 
  • Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. 
  • Atrial fibrillation: conventional wisdom reappraised. 
  • Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events. 
  • Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries. 
  • Background factors and clinical symptoms of major depression with silent cerebral infarction. 
  • Barbiturate protection and cardiac surgery: a different result. 
  • Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). 
  • Blood flow imaging of a posterior circulation stroke. Use of technetium Tc 99m hexamethylpropyleneamine oxime and single photon emission computed tomography. 
  • Bone marrow transplantation for sickle cell disease. 
  • Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study. 
  • CVD mortality, 1968-1978: observations and implications. 
  • Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). 
  • Cause specific mortality patterns among the oldest old: multiple cause of death trends 1968 to 1980. 
  • Cerebral magnetic resonance findings in asymptomatic patients after atrial fibrillation catheter ablation: cause for alarm or further study? 
  • Cerebrovascular disease and depression symptoms in the cardiovascular health study. 
  • Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. 
  • Cerebrovascular risk factors and cerebral hyperintensities among middle-aged and older adults with major depression. 
  • Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression. 
  • Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease. 
  • Circadian variation in ischemic stroke subtypes. 
  • Clinical Crossroads: a 36-year-old woman recuperating from stroke. 
  • Clinical Crossroads: a 36-year-old woman recuperating from stroke. 
  • Clinical and angiographic correlates of short- and long-term mortality in patients undergoing coronary artery bypass grafting. 
  • Clinical assessment of MR of the brain in nonsurgical inpatients. 
  • Clinical preventive practice. 
  • Clinical stroke trials: guarding against bias. 
  • Clonidine impairs recovery of beam-walking after a sensorimotor cortex lesion in the rat. 
  • Cognitive dysfunction after cardiac surgery: revisiting etiology. 
  • Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. 
  • Common drugs may influence motor recovery after stroke. The Sygen In Acute Stroke Study Investigators. 
  • Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality. 
  • Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty. 
  • Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. 
  • Cortical cerebral microinfarcts on 3T MRI: A novel marker of cerebrovascular disease. 
  • Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. 
  • Costs and outcomes of hip fracture and stroke, 1984 to 1994. 
  • Cyclosporin A-related cerebral vasculopathy. 
  • Decision making in the face of uncertainty: the case of carotid endarterectomy. 
  • Deconstructing racial differences: the effects of quality of education and cerebrovascular risk factors. 
  • Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III Investigators. 
  • Depressive symptomatology and hypertension-associated morbidity and mortality in older adults. 
  • Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). 
  • Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke Study, 1989-1990. 
  • Developmental and lesion effects in brain activation during sentence comprehension and mental rotation. 
  • Diagnosis of intracranial vasculitis: a multi-disciplinary approach. 
  • Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease. 
  • Early recurrent ischemic stroke. A case-control study. 
  • Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon Pump. 
  • Effect of niacin on atherosclerotic cardiovascular disease. 
  • Effects of admission to a teaching hospital on the cost and quality of care for Medicare beneficiaries. 
  • Effects of dependency among causes of death for cause elimination life table strategies. 
  • Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study. 
  • Emergency management of the patient with seizures. 1. Classification and treatment system, common seizure disorders. 
  • Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology. 
  • Endarterectomy in carotid artery disease. A decision analysis. 
  • Endothelial dysfunction in cerebral microcirculation during hypothermic cardiopulmonary bypass in newborn lambs. 
  • Endovascular stroke intervention in young patients with large vessel occlusions. 
  • Epsilon-aminocaproic acid administration and stroke following coronary artery bypass graft surgery. 
  • Establishing diagnostic criteria for vascular depression. 
  • Estimates of U.S. multiple cause life tables. 
  • Evaluation of the Heart and Stroke Foundation of Canada Research Scholarship Program: research productivity and impact. 
  • Evidence-based medicine and stroke. 
  • Evolving role of biomarkers in acute cerebrovascular disease. 
  • Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study. 
  • Food group intake and brain lesions in late-life vascular depression. 
  • Ganglioside GM1 in acute ischemic stroke. The SASS Trial. 
  • Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. 
  • Geriatric depression and cognitive impairment. 
  • Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. 
  • Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. 
  • Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. 
  • Guidelines on the use of thrombolytic agents in stroke. 
  • Health status of individuals with mild stroke. 
  • High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. 
  • Hospitalization and case-fatality rates for stroke in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations. 
  • Hospitalization and case-fatality rates for subarachnoid hemorrhage in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations. 
  • How should a patient presenting with unstable angina and a recent stroke be managed? 
  • Hydroxyurea: an alternative to transfusion therapy for stroke in sickle cell anemia. 
  • Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients. 
  • Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. 
  • Imaging and genetics advances in understanding geriatric depression. 
  • Imaging of Cerebrovascular Disease in Pregnancy and the Puerperium. 
  • Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery. 
  • Impact of social support on outcome in first stroke. 
  • Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease. 
  • Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach. 
  • Influence of projected complication rates on estimated appropriate use rates for carotid endarterectomy. Appropriateness Project Investigators. Academic Medical Center Consortium. 
  • Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals. 
  • Insights derived from the thrombolysis and angioplasty in myocardial infarction (TAMI) trials. 
  • Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators. 
  • Interrater reliability of the NIH stroke scale. 
  • Intra-Arterial Chemotherapy Opens New Horizons to Neurointerventional Surgeons 
  • Intracranial fibromuscular dysplasia in a 5-year-old child. 
  • Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment. 
  • John Henryism and the health of African-Americans. 
  • Knowledge of risk among patients at increased risk for stroke. 
  • Large-dose infusions of heparinoid ORG 10172 in ischemic stroke. 
  • Leading Causes of Death among Asian American Subgroups (2003-2011). 
  • Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials. 
  • Licorice-associated reversible cerebral vasoconstriction with PRES. 
  • Lipids and stroke: a paradox resolved. 
  • Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study. 
  • MCA flow asymmetry is a marker for cerebrovascular disease. 
  • MR arteriography of intracranial circulation. 
  • MRI lesion severity and mortality in geriatric depression. 
  • Measurement of motor recovery after stroke. Outcome assessment and sample size requirements. 
  • Medical treatment for stroke prevention. 
  • Meningitis, vasculitis, and cerebritis caused by CNS histoplasmosis: radiologic-pathologic correlation. 
  • Microsurgical resection of vestibular schwannomas: complication avoidance. 
  • Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. 
  • Mood disorders in the medically ill: scientific review and recommendations. 
  • Mortality model based on delays in progression of chronic diseases: alternative to cause elimination model. 
  • Mortality of the chronically impaired. 
  • Mr. Piano Man: reflections on the life of physician, scientist, and humanitarian, William L. Young, MD (1954-2013). 
  • Multi-stage segmentation of white matter hyperintensity, cortical and lacunar infarcts. 
  • Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. 
  • Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. 
  • Multicenter review of preoperative risk factors for endarterectomy for asymptomatic carotid artery stenosis. 
  • Myocardial infarction and stroke. 
  • National trends in stroke-related mortality: a comparison of multiple cause mortality data with survey and other health data. 
  • Natural history of cerebral complications of coronary artery bypass graft surgery. 
  • Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. 
  • Neurologic outcomes after coronary artery bypass grafting with and without cardiopulmonary bypass. 
  • Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries. 
  • Neurovascular coupling during spreading depolarizations. 
  • Nocturnal blood pressure, morning blood pressure surge, and cerebrovascular events. 
  • Nontraumatic neurologic emergencies: imaging findings and diagnostic pitfalls. 
  • North Carolina stroke prevention and treatment facilities survey: rtPA therapy for acute stroke. 
  • Novel polymorphism in the A4 region of the amyloid precursor protein gene in a patient without Alzheimer's disease. 
  • Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. 
  • Orbital phlebography in the study of cavernous sinus disease. 
  • Patient preferences for stroke outcomes. 
  • Perioperative morbidity and mortality in combined vs. staged approaches to carotid and coronary revascularization. 
  • Peripheral vascular disease. Diagnosing and treating the 3 most common peripheral vasculopathies. 
  • Pharmacokinetics of 619C89, a novel neuronal sodium channel inhibitor, in acute stroke patients after loading and discrete maintenance infusions. 
  • Pharmacology of recovery after stroke. 
  • Physician prescribing patterns following hospital admission for ischemic cerebrovascular disease. 
  • Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction. 
  • Population impact of mortality reduction: the effects of elimination of major causes of death on the 'saved' population. 
  • Post-stroke depression in the elderly. 
  • Potential effects of common drugs on stroke recovery. 
  • Predicting and preventing adverse neurologic outcomes with cardiac surgery. 
  • Predicting complications of carotid endarterectomy. 
  • Predicting the cost of illness: a comparison of alternative models applied to stroke. 
  • Predicting the cost of illness: a comparison of alternative models applied to stroke. 
  • Predictors of length of hospital stay in elderly hip fracture patients. 
  • Preoperative risk factors for carotid endarterectomy. 
  • Presenting pulse pressure predicts thrombolytic therapy-related intracranial hemorrhage. Thrombolytic Predictive Instrument (TPI) Project results. 
  • Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association. 
  • Primary care physician-reported secondary and tertiary stroke prevention practices. A comparison between the United States and the United Kingdom. 
  • Primary prevention of stroke. 
  • Primum non nocere: antithombotics after intracerebral hemorrhage? 
  • Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. 
  • Priorities for comparative effectiveness reviews in cardiovascular disease. 
  • Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT. 
  • Progression of impairment in patients with vascular cognitive impairment without dementia. 
  • Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions. 
  • Racial differences in the utilization of inpatient rehabilitation services among elderly stroke patients. 
  • Racial variations in ischemic stroke-related physical and functional impairments. 
  • Radiologic intervention in the acute stroke patient. 
  • Radionuclide emission computed tomography of the head with 99mCc and a scintillation camera. 
  • Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. 
  • Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. 
  • Re: Total prostatoseminal vesiculectomy in the treatment of debilitating perineal pain. 
  • Recent advances in imaging of cerebrovascular disease. 
  • Recurrent transient ischemic attacks and stroke in association with an internal carotid artery web. 
  • Regional cerebral blood flow estimated by 133-xenon inhalation. 
  • Relation between BMI and diabetes mellitus and its complications among US older adults. 
  • Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators. 
  • Releasable vascular plasminogen activator and thrombotic strokes. 
  • Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. 
  • Reply: To PMID 24360877. 
  • Restorative neurology. Drugs and recovery following stroke. 
  • Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. 
  • Retinal microvascular signs and cognitive impairment. 
  • Retinal microvascular signs and risk of stroke and stroke mortality. 
  • Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. 
  • Retrospective assessment of initial stroke severity with the Canadian Neurological Scale. 
  • Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. 
  • Risk of cerebrovascular events in elderly patients after radiation therapy versus surgery for early-stage glottic cancer. 
  • Risk of late stroke and survival following carotid endarterectomy procedures for symptomatic patients. 
  • Sample size calculations for clinical trials using the NIH Stroke Scale. 
  • Saphenous vein versus polytetrafluoroethylene carotid patch angioplasty. 
  • Secular trends in ischemic heart disease mortality: regional variation. 
  • Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation. 
  • Silent aspiration following stroke. 
  • Similar motor recovery of upper and lower extremities after stroke. 
  • Six-month outcomes for MRI-related vascular depression. 
  • Speech therapy for aphasic stroke patients. 
  • Statin therapy--Part II: Clinical considerations for cardiovascular disease. 
  • Statins after intracerebral hemorrhage: to treat or not to treat. 
  • Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis. 
  • Stroke disability. 
  • Stroke due to recurrent ipsilateral carotid artery dissection in a young adult. 
  • Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. 
  • Stroke prevention: the emerging strategies. 
  • Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. 
  • Substance abuse and cerebral blood flow. 
  • Sumatriptan-induced stroke in sagittal sinus thrombosis. 
  • Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. 
  • Surgical management of carotid artery atherosclerotic disease. 
  • Survival and outcome after endotracheal intubation for acute stroke. 
  • Systematic review of CT and MR perfusion imaging for assessment of acute cerebrovascular disease. 
  • Systemic associations of retinal microvascular signs: a review of recent population-based studies. 
  • T2 hyperintensity of medial lemniscus: higher threshold application to ROI measurements is more accurate in predicting small vessel disease. 
  • Temporal trends in U. S. multiple cause of death mortality data: 1968 to 1977. 
  • The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES). 
  • The Stroke P.O.R.T.: secondary and tertiary prevention of ischemic stroke. Stroke Prevention Patient Outcomes Research Team. 
  • The Stroke Prevention Patient Outcomes Research Team. Goals and methods. 
  • The Stroke Prevention Policy Model: linking evidence and clinical decisions. 
  • The Vascular Impairment of Cognition Classification Consensus Study. 
  • The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype. 
  • The dynamics of dimensions of age-related disability 1982 to 1994 in the U.S. elderly population. 
  • The impact of coronary artery disease on carotid endarterectomy. 
  • The importance of family history in cerebrovascular disease. 
  • The rational clinical examination. Clinical assessment of stroke. 
  • The risk of radiation-induced cerebrovascular disease in Chernobyl emergency workers. 
  • The risk of stroke after thrombolytic therapy. 
  • The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. 
  • The value of stroke prevention and treatment. 
  • Theories explaining racial differences in the utilization of diagnostic and therapeutic procedures for cerebrovascular disease. 
  • Therapy of seizures associated with stroke. 
  • Thrombolysis for stroke: pushed out of the window? 
  • Thrombolytic therapy for elderly patients. 
  • Thrombotic and cardiovascular complications related to nonionic contrast media during cardiac catheterization: analysis of 8,517 patients. 
  • Tissue plasminogen activator for acute ischemic stroke. 
  • Toward a new frontier in cardiac surgery. 
  • Transesophageal echocardiography in diagnosing cardioembolic stroke. 
  • Trials of streptokinase in stroke depend on early, accurate diagnosis. 
  • Two surgeons four-hand microneurosurgery with universal holder system: technical note. 
  • US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Carotid endarterectomy. 
  • US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Medical therapy in patients with carotid artery stenosis. 
  • US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices. 
  • Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry. 
  • Use of common antiplatelet drugs for vascular diseases. 
  • Utility of postmortem magnetic resonance imaging in clinical neuropathology. 
  • Validation of the Total Cerebrovascular Disease Burden Scale in a Community Sample. 
  • Vascular depression consensus report - a critical update. 
  • Vascular nutritional correlates of late-life depression. 
  • Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. 
  • Ventilatory management in critical neurologic illness. 
  • Vertical gaze paralysis and intermittent unresponsiveness in a patient with a thalamomesencephalic stroke. 
  • What are the causes of late-life depression? 
  • What role do neurologists play in determining the costs and outcomes of stroke patients? 
  • When and how to study the carotid arteries. 
  • Worse outcomes for patients undergoing brain tumor and cerebrovascular procedures following the ACGME resident duty-hour restrictions. 
  • [Neurology and cardiology: points of contact]. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Doraiswamy, P. Murali, Professor of Psychiatry and Behavioral Sciences, Duke Science & Society
  • James, Michael Lucas, Associate Professor of Anesthesiology, Anesthesiology, Neuroanesthesia
  • Laskowitz, Daniel Todd, Professor of Neurology, Duke Innovation & Entrepreneurship
  • MacFall, James R., Adjunct Professor in the Department of Radiology, Radiology
  • McConnell, Eleanor Schildwachter, Associate Professor in the School of Nursing, with tenure, School of Nursing
  • Muir, Kelly Walton, Associate Professor of Ophthalmology, Ophthalmology, Glaucoma
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. / Guidant Foundation Professor of Cardiology, Medicine, Clinical Pharmacology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Immunology
  • Swaminathan, Madhav, Professor of Anesthesiology, Anesthesiology, Cardiothoracic
  • Warner, David Samuel, Distinguished Professor of Anesthesiology, in the School of Medicine, Neurobiology